| spelling |
oapen-20.500.12657-470392021-03-05T02:28:47Z Chapter Mapping Jewish Identities Mozersky, Jessica Gibbon, Sahra brca breast cancer comparison research UK Brazil bic Book Industry Communication::J Society & social sciences::JF Society & culture: general bic Book Industry Communication::J Society & social sciences::JH Sociology & anthropology::JHM Anthropology::JHMC Social & cultural anthropology, ethnography bic Book Industry Communication::J Society & social sciences::JH Sociology & anthropology::JHB Sociology Through a comparion of etnographic research in the UK and Brazil, this chapter has examined now changing scientific and medical understandings regarding the origin, genealogical history and patrimony of the so-called Ashkenazi mutations have been diversely taken up and put to use in clinical/research contexts. It has explored the very differing differing differing consequences this can have for the way health care practitioners, scientists, patients and their families engage with and incorporate knowledge about hereditary BRCA mutations into scientific narratives, clinical practices and understandings of clinical/familial risk and identity. 2021-03-04T11:02:12Z 2021-03-04T11:02:12Z 2014 chapter https://library.oapen.org/handle/20.500.12657/47039 eng application/pdf Attribution-NonCommercial-NoDerivatives 4.0 International Bookshelf_NBK554740.pdf Taylor & Francis Breast Cancer Gene Research and Medical Practices Routledge 7b3c7b10-5b1e-40b3-860e-c6dd5197f0bb ad1d6d71-681f-4560-95df-6e258484368d d859fbd3-d884-4090-a0ec-baf821c9abfd Wellcome Routledge Wellcome Trust Wellcome open access
|
| description |
Through a comparion of etnographic research in the UK and Brazil, this chapter has examined now changing scientific and medical understandings regarding the origin, genealogical history and patrimony of the so-called Ashkenazi mutations have been diversely taken up and put to use in clinical/research contexts. It has explored the very differing differing differing consequences this can have for the way health care practitioners, scientists, patients and their families engage with and incorporate knowledge about hereditary BRCA mutations into scientific narratives, clinical practices and understandings of clinical/familial risk and identity.
|
